GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
BMI1 | 1066 | LTM | Dukes Type B Colon Cancer | Adenocarcinoma | LS174T | NA | FACs followed by Western Blotting and RT-PCR | NA | 0.6 | 0.1135 | 22384170
|
LGR5 | 4504 | LTM | Dukes Type B Colon Cancer | Adenocarcinoma | LS174T | NA | FACs followed by Western Blotting and RT-PCR | NA | 0.6 | 0.0753 | 22384170
|
MYC | 7553 | LTM | Dukes Type B Colon Cancer | Adenocarcinoma | LS174T | NA | FACs followed by Western Blotting and RT-PCR | NA | 0.6 | 0.1304 | 22384170
|
POU5F1 | 9221 | LTM | Dukes Type B Colon Cancer | Adenocarcinoma | LS174T | NA | FACs followed by Western Blotting and RT-PCR | NA | 0.6 | 0.6448 | 22384170
|
PROM1 | 9454 | LTM | Dukes Type B Colon Cancer | Adenocarcinoma | LS174T | NA | FACs followed by Western Blotting and RT-PCR | NA | 0.6 | 0.7582 | 22384170
|
PROM1 | 9454 | LTM | Dukes Type B Colon Cancer | Adenocarcinoma | LS174T | NA | SFA and FACs | NA | 0.6 | 0.7582 | 25804133
|
SOX2 | 11195 | LTM | Dukes Type B Colon Cancer | Adenocarcinoma | LS174T | NA | FACs followed by Western Blotting and RT-PCR | NA | 0.6 | 0.5695 | 22384170
|
ALCAM | 400 | LTM | Dukes Type B Colon Cancer | Adenocarcinoma | LS174T | NA | SFA and FACs | NA | 0.12 | 0.0583 | 25804133
|
CD24 | 1645 | LTM | Dukes Type B Colon Cancer | Adenocarcinoma | LS174T | NA | FACs | NA | 0.12 | 0.456 | 27520449
|
CD44 | 1681 | LTM | Dukes Type B Colon Cancer | Adenocarcinoma | LS174T | NA | FACs | NA | 0.12 | 1 | 27520449
|
EPCAM | 11529 | LTM | Dukes Type B Colon Cancer | Adenocarcinoma | LS174T | NA | SFA and FACs | NA | 0.12 | 0.211 | 25804133
|